(Q60685431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

main subject

phase II clinical trial

1 reference

inferred from title

author

Vanna Chiarion Sileni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Silvio Monfardini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Antonio Bononi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Cleto Veller Fornasa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Mariella Soraru

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Mauro Alaibac

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Eros Ferrazzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Roberta Redelotti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Andrea Peserico

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Luigi Salvagno

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

number of pages

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

569-575

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Topical corticosteroids for mycosis fungoides. Experience in 79 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Psoralen photochemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Total skin electron beam irradiation for cutaneous T-cell lymphoma (mycosis fungoides).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Photopheresis for the treatment of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Primary cutaneous T-cell lymphoma: review and current concepts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10706

7 January 2021

Identifiers

DOI

10.1002/CNCR.10706

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209749%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference